CYLD and acute myeloid leukemia: Moreover, the mRNA level of CYLD was increased upon treatment of BMDMs with STAT-1 signaling inhibitor fludarabine or STAT1 siRNA, we asked therefore whether STAT1 signalling is related to the inhibitory role of CYLD on functions of BMDMs from AML patients.